Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer

b3cnewswireApril 09, 2019

Tag: Queen’s University , Domainex , cancer

PharmaSources Customer Service